
    
      Screening: 2-3 weeks prior to enrollment in Stage 1.

      Stage 1 (Run-In): 1-4weeks depending on qualification for Stage 2.

      Stage 2 (Randomized Blinded Treatment): 12 months unless withdrawn prematurely.

      Stage 3 (Open-Label Treatment): The duration of Stage 2 plus Stage 3 is intended to be 18
      months regardless of treatment assignment in Stage 2.
    
  